DoctoRx's Optimal Formula, Dry Eye Formula, Ocular Support Softgel, 60 Softgels/Dietary Supplement — FDA record F-0352-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Nov 30, 2021. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
DoctoRx's Optimal Formula, Dry Eye Formula, Ocular Support Softgel, 60 Softgels/Dietary Supplement
Reason
Undeclared fish allergen
Classification
Class II
Recalling firm
Golden Lab LLC
Quantity
13,079 units
Agency-reported status
Terminated
Source record identifier
F-0352-2022

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityLots: D93210669 and E11290344

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Domestic distribution only.

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Report date
Dec 29, 2021
Recall initiation date
Nov 30, 2021
Center classification date
Dec 23, 2021
Termination date
Mar 15, 2022

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records